Arizona Center for Cancer Care

Glendale, Arizona 85306

0 studies enrolling now · 11 studies all time

What they study most

Breast Cancer, Breast Tumor, Cancer of the Breast, Chronic Myelomonocytic Leukemia (CMML), Colorectal Cancer, Epithelial Ovarian Cancer, Estrogen Receptor- Negative Breast Cancer, Fallopian Tube Cancer, HER2- Negative Breast Cancer, Her2 Negative Breast Cancer Patients, Lymphoma, Non-Hodgkin, Metastatic Breast Cancer

Studies at this site

• Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies — Completed
• Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) — Completed
• Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) — Completed
• Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer — Completed
• SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE) — Completed
• NBRST: Prospective Neo-adjuvant REGISTRY Trial — Completed
• Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) — Completed
• A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) — Completed
• Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL — Stopped early
• A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers — Completed
• Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer — Completed